These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 3368337)
21. 24-Hour/4-hour ratio of technetium-99m methylene diphosphonate uptake in patients with bone metastases and degenerative bone changes. Israel O; Front D; Frenkel A; Kleinhaus U J Nucl Med; 1985 Mar; 26(3):237-40. PubMed ID: 3156220 [TBL] [Abstract][Full Text] [Related]
22. [A phosphine-substituted diphosphonic acid (HMPD) for improved scintigraphic detection of bone lesions]. Steinsträsser A; Schwarz A; Alexander C; Berberich R; Zimmer M Nuklearmedizin; 1992 Oct; 31(5):164-71. PubMed ID: 1465353 [TBL] [Abstract][Full Text] [Related]
23. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)? Frühling J; Verbist A; Balikdjian D Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485 [TBL] [Abstract][Full Text] [Related]
24. A clinical comparison of MDP and DMAD. Rosenthall L; Stern J; Arzoumanian A Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358 [TBL] [Abstract][Full Text] [Related]
25. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent. Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556 [TBL] [Abstract][Full Text] [Related]
26. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer. Coleman RE; Meier CA; Rubens RD; Fogelman I Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907 [TBL] [Abstract][Full Text] [Related]
27. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content. Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106 [TBL] [Abstract][Full Text] [Related]
28. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)]. Knop J; Montz R Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781 [TBL] [Abstract][Full Text] [Related]
29. Detection of a brain metastasis from osteosarcoma with 99mTc-methylene diphosphonate bone scanning. Ozarda AT; Legaspi JR; Haynie TP Eur J Nucl Med; 1983; 8(12):552-4. PubMed ID: 6230234 [TBL] [Abstract][Full Text] [Related]
30. Influence of the phosphate balance on the activity distribution of 99mTc-hydroxy-methylene diphosphonate. Experimental studies in the mouse. Cronhjort M; Sääf M; Sjöberg HE; Schnell PO; Jacobsson H Acta Radiol; 1998 Jul; 39(4):427-33. PubMed ID: 9685832 [TBL] [Abstract][Full Text] [Related]
31. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate. Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning]. Yang JS Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062 [No Abstract] [Full Text] [Related]